News

22.11.2021 | EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control
Mon, 15.11.2021 Press release
27.08.2021 | Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation Asymptomatic patients with atrial fibrillation (AF) benefit from early rhythm control therapy comparably to...
25.08.2021 | EAST-AFNET 4 @ ESC Congress 2021
The latest results of the EAST - AFNET 4  study will be presented at this year's ESC congress:
30.07.2021 | Patients with atrial fibrillation and heart failure benefit from early rhythm control
A subgroup analysis of the EAST – AFNET 4 study population revealed: Early initiation of rhythm control therapy is associated with clinical benefit in patients with heart failure and recently...
19.07.2021 | EAST-AFNET 4 @ HRS 2021
The latest results of the EAST - AFNET 4  study will be presented at this year's HRS in Boston.
29.08.2020 | EAST - AFNET 4 results
Early rhythm control therapy improves outcomes in patients with atrial fibrillation

Left Sidebar

EAST-AFNET 4 an AFNET/EHRA Trial


 


 

News

22.11.2021 | EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control
Mon, 15.11.2021 Press release
27.08.2021 | Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation Asymptomatic patients with atrial fibrillation (AF) benefit from early rhythm control therapy comparably to...
25.08.2021 | EAST-AFNET 4 @ ESC Congress 2021
The latest results of the EAST - AFNET 4  study will be presented at this year's ESC congress:

more NEWS